Cargando…
A Prognostic Signature for Colon Adenocarcinoma Patients Based on m6A-Related lncRNAs
N6-methyladenosine (m6A) modification is a common epigenetic modification. It is reported that lncRNA can be regulated by m6A modification. Previous studies have shown that lncRNAs associated with m6A regulation (m6A-lncRNAs) serve as ideal prognostic biomarkers. However, whether lncRNAs are involve...
Autores principales: | Zhou, Su-Zhe, Pan, Ying-Lian, Deng, Qing-Chun, Yin, Chang-Jun, Zhou, De-Jiang, Liu, Ming-Liang, Zhou, Jun, Wu, Xiao-Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940948/ https://www.ncbi.nlm.nih.gov/pubmed/36814559 http://dx.doi.org/10.1155/2023/7797710 |
Ejemplares similares
-
A Novel Prognostic Chemokine-Related lncRNAs Signature Associated with Immune Landscape in Colon Adenocarcinoma
por: Dai, Xinglong, et al.
Publicado: (2022) -
Metabolism‐related lncRNAs signature to predict the prognosis of colon adenocarcinoma
por: Sun, Yimin, et al.
Publicado: (2022) -
5mC-Related lncRNAs as Potential Prognostic Biomarkers in Colon Adenocarcinoma
por: Huang, Yinghui, et al.
Publicado: (2022) -
Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
por: Li, Chong, et al.
Publicado: (2023) -
A Ferroptosis-Related lncRNAs Signature Predicts Prognosis of Colon Adenocarcinoma
por: Guo, Ying, et al.
Publicado: (2023)